Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Aerovate Therapeutics, Inc. (AVTE) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/14/2023 8-K Quarterly results
08/07/2023 144 Form 144 - Report of proposed sale of securities:
07/28/2023 144 Form 144 - Report of proposed sale of securities:
07/17/2023 144 Form 144 - Report of proposed sale of securities:
07/11/2023 8-K Quarterly results
07/06/2023 144 Form 144 - Report of proposed sale of securities:
07/05/2023 144 Form 144 - Report of proposed sale of securities:
07/03/2023 144 Form 144 - Report of proposed sale of securities:
06/08/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
06/06/2023 144 Form 144 - Report of proposed sale of securities:
06/05/2023 144 Form 144 - Report of proposed sale of securities:
05/19/2023 144 Form 144 - Report of proposed sale of securities:
05/17/2023 144 Form 144 - Report of proposed sale of securities:
05/08/2023 144 Form 144 - Report of proposed sale of securities:
05/05/2023 144 Form 144 - Report of proposed sale of securities:
05/02/2023 144 Form 144 - Report of proposed sale of securities:
05/01/2023 144 Form 144 - Report of proposed sale of securities:
04/19/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/19/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/19/2023 ARS Form ARS - Annual Report to Security Holders:
04/05/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "ATM Equity OfferingSM Sales Agreement, by and between Aerovate Therapeutics, Inc. and BofA Securities, Inc"
04/05/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
03/29/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/29/2023 10-K Annual Report for the period ended December 31, 2022
03/29/2023 8-K Quarterly results
02/14/2023 SC 13G/A BAKER BROS. ADVISORS LP reports a 8% stake in Aerovate Therapeutics, Inc.
02/14/2023 SC 13G/A Cormorant Asset Management, LP reports a 8% stake in Aerovate Therapeutics, Inc.
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/23/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
12/15/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
11/14/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/14/2022 8-K Quarterly results
08/24/2022 EFFECT Form EFFECT - Notice of Effectiveness:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy